Chris Barker, an Independent Statistical Consultant, discusses the differences and biases in summaries obtained from a database called PDQ vs. CTG.
Chris Barker
Advertisement
Articles by Chris Barker
Advertisement
Latest Updated Articles
Biases in Characterization of Oncology Trials for Policy DecisionsPublished: July 31st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Reframing the IND: From Tactical Requirement to Strategic Opportunity
4
Streamlining Trial Design to Accelerate Data Delivery and Investor Confidence
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
